JPRN-UMIN000006743Completed未知
Progression of Axial Myopia in Childhood is Associated with Blurring of Peripheral Retinal Image due to Hyperopic Defocus, not due to Higher-order Aberration - Progression of Axial Myopia in Childhood is Associated with Blurring of Peripheral Retinal Image due to Hyperopic Defocus, not due to Higher-order Aberration
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Tokyo Dental College
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 8years-old to 20years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Children with binocular vision conditions with strabismus, any ocular or systemic condition associated with myopia (e.g., Marfan syndrome, retinopathy of prematurity, etc), a history of orthokeratology lens wear, bifocal or progressive addition spectacles in the past 12 months, atropine treatment for myopia control, or known allergy to tropicamide or phenylephrine were excluded from this study.
Investigators
Similar Trials
Not yet recruiting
Unknown
Progression of myopia or short sightedness in children following surgery for intermittent exotropia which is characterized by occasional outward deviation of one or both eyes.CTRI/2024/03/064786Purva Kavishwar
Enrolling By Invitation
Not Applicable
Axial Length With Adult Onset Myopia (ALWAOM)MyopiaNCT05559567Art Optical Contact Lens, Inc.100
Completed
Not Applicable
To determine the rate of refractive error change in children wearing multifocal soft contact lens as compared to those wearing single vision soft contact lensesEye - Normal eye development and functionMyopiaACTRN12611001148965Brien Holden Vision Institute (at the time of the trial known as Institute for Eye Research)40
Active, not recruiting
Phase 1
Study of slowing progression (worsening) of school myopia (short-sightedness) in children by testing very low dose atropine eye drops against placebo eye drops (drops without atropine).Myopia progressionMedDRA version: 20.0 Level: PT Classification code 10028651 Term: Myopia System Organ Class: 10015919 - Eye disordersEUCTR2018-001077-24-ESevakar Inc.483
Completed
Phase 3
Childhood Atropine for Myopia Progression (CHAMP): A 3-Arm Randomized, Double-Masked, Placebo-Controlled, Phase 3 Study of Atropine Sulfate Ophthalmic Solution 0.01% and 0.02%NL-OMON55813Vyluma Inc.40
